— Know what they know.
Not Investment Advice

STXS AMEX

Stereotaxis, Inc.
1W: -2.1% 1M: -2.1% 3M: -8.2% YTD: -18.1% 1Y: -9.1% 3Y: +8.0% 5Y: -72.3%
$1.92
+0.02 (+1.05%)
 
Weekly Expected Move ±5.6%
$2 $2 $2 $2 $2
AMEX · Healthcare · Medical - Instruments & Supplies · Alpha Radar Neutral · Power 44 · $187.7M mcap · 69M float · 0.599% daily turnover · Short 62% of daily vol

Cash Flow Trends

Operating Cash Flow
-$14M -61.1% ▼
Capital Expenditures
$93K -173.5% ▼
5Y CAGR: +5.6%
Free Cash Flow
-$14M -61.5% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$985K +112.1% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$11M-$18M-$21M-$24M-$22M
Depreciation & Amort.$106K$429K$595K$969K$2M
Stock-Based Comp.$9M$11M$11M$10M$10M
Change in Working Capital$135K-$1M$612K$3M-$6M
Other Non-Cash Items-$2M-$25K-$256K$2M$2M
Operating Cash Flow-$3M-$8M-$9M-$8M-$14M
— Investing Activities —
Capital Expenditures-$1M-$2M-$366K-$34K-$93K
Acquisitions (Net)$0$0$0$108K$0
Investment Purchases$0-$20M$0$0$0
Investment Sales$0$0$20M$0$0
Other Investing$0$0$0$0$0
Investing Cash Flow-$1M-$22M$20M$74K-$93K
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$0$0$0
Financing Cash Flow$547K$220K$81K$297K$15M
Net Change in Cash-$4M-$30M$11M-$8M$985K
Cash End of Period$40M$10M$21M$12M$13M
Free Cash Flow-$4M-$11M-$10M-$9M-$14M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms